Bicycle: Bicycle Therapeutics plc: Bicycle Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference
Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle) technology, today an...
Read full article »
Bicycle is an England-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of cancer and inflammatory diseases.
Read more